1. Home
  2. GNPX vs GCDT Comparison

GNPX vs GCDT Comparison

Compare GNPX & GCDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Genprex Inc.

GNPX

Genprex Inc.

HOLD

Current Price

$0.77

Market Cap

11.8M

Sector

Health Care

ML Signal

HOLD

GCDT

Green Circle Decarbonize Technology Limited Ordinary Shares

N/A

Current Price

$0.68

Market Cap

9.9M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
GNPX
GCDT
Founded
2009
1992
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
11.8M
9.9M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
GNPX
GCDT
Price
$0.77
$0.68
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
708.5K
34.9K
Earning Date
05-11-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$0.66
52 Week High
$12.97
$5.32

Technical Indicators

Market Signals
Indicator
GNPX
GCDT
Relative Strength Index (RSI) 25.43 33.68
Support Level $0.15 N/A
Resistance Level $2.12 $1.50
Average True Range (ATR) 0.06 0.10
MACD 0.02 0.02
Stochastic Oscillator 8.39 17.54

Price Performance

Historical Comparison
GNPX
GCDT

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is initially being developed in combination with prominent, approved cancer drugs to treat Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC).

About GCDT Green Circle Decarbonize Technology Limited Ordinary Shares

Green Circle Decarbonize Technology Ltd is a company which provides advanced energy saving solutions supported by proprietary phase change thermal energy storage materials and thermal engineering services. As an advocate of decarbonization, the Company designs, develops and provides customized energy saving solutions that bring considerable economic benefits to our clients and reduce carbon emissions for a sustainable future.

Share on Social Networks: